Immune myopathy with large histiocyte-related myofiber necrosis
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received March 17, 2018
- Accepted in final form December 10, 2018
- First Published March 20, 2019.
Article Versions
- Previous version (March 20, 2019 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Alan Pestronk, MD,
- Namita Sinha, MD,
- Ziad Alhumayyd, MD,
- Cindy Ly, MD,
- Robert Schmidt, MD and
- Robert Bucelli, MD
- Alan Pestronk, MD,
NONE
NONE
NONE
NONE
(1) TS-HDS antibody 7,175,989, issued 2007; (2) GALOP antibody 6,121,004, issued 2000; (3) GM1 ganglioside antibody 6,077,681, issued 2000; (4) Sulfatide antibody 6,020,140, issued 1995 (5) NS6S antibody 9,535,072, issued 2017
NONE
NONE
NONE
NONE
NONE
NONE
(1) Ionis, (2) Biogen, (3) Idera, (4) Ultragenyx, (5) Acceleron, (6) Cytokinetics, (7) Sanofi, (8) Amicus
NIH
Washington University Neuromuscular Research Fund
(1) Muscular Dystrophy Association, Clinic Director 1989 - 2019
Johnson & Johnson, hold stock
Antibody testing, Athena
(1) GALOP antibody 6,121,004, issued 2000; (2) GM1 ganglioside antibody 6,077,681, issued 2000; (3) Sulfatide antibody 6,020,140; issued 1995
NONE
NONE
NONE
- Namita Sinha, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ziad Alhumayyd, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Cindy Ly, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Dr. Ly receives funding support from NIH K08 NS107621, PI, 2018
NONE
Dr. Ly received funding support from an American Association of Neurology/ American Brain Foundation/ ALS Association sponsored Clinical Research Training Fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Robert Schmidt, MD and
NONE
NONE
NONE
1) Brain Pathology, Senior Editor 2) Journal of Neuropathology Experimental Neurology, Editorial Board
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Robert Bucelli, MD
I was asked to participate in an advisory board meeting for MT Pharma prior to the launch of edaravone. This was limited to a single meeting and I have no ongoing ties to MT Pharma.
1) Parents of a family member I care for with Parsonage Turner syndrome, a recurring annual financial gift has been provided to me in hopes that it could be used towards Parsonage Turner research.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I have equity in the Neurology board review website called Neuroquestions, LLC
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Departments of Neurology (A.P., C.L., R.B.) and Pathology and Immunology (A.P., N.S., R.S.), Washington University School of Medicine, Saint Louis, MO; and Department of Neurology (Z.A.), King Saud University, Riyadh, Saudi Arabia.
- Correspondence
Dr. Pestronk pestronka{at}neuro.wustl.edu
Article usage
Cited By...
Letters: Rapid online correspondence
- Author response: Immune myopathy with large histiocyte-related myofiber necrosis
- Alan Pestronk, Neuromuscular Physician, Departments of Neurology and Pathology & Immunology, Washington University in Saint Louis
Submitted May 27, 2019 - Reader response: Immune myopathy with large histiocyte-related myofiber necrosis
- Kenichiro Taira, Neurologist, National Center Hospital, National Center of Neurology and Psychiatry
Submitted April 21, 2019
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jessica Ailani and Dr. Ailna Masters-Israilov
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Myopathy with anti-HMGCR antibodiesPerimysium and myofiber pathologyAli Alshehri, Rati Choksi, Robert Bucelli et al.Neurology - Neuroimmunology Neuroinflammation, June 04, 2015 -
Article
Necrosis in anti-SRP+ and anti-HMGCR+myopathiesRole of autoantibodies and complementYves Allenbach, Louiza Arouche-Delaperche, Corinna Preusse et al.Neurology, January 12, 2018 -
Article
Nuclear actin aggregation is a hallmark of anti-synthetase syndrome–induced dysimmune myopathyWerner Stenzel, Corinna Preuße, Yves Allenbach et al.Neurology, March 06, 2015 -
Article
Immune myopathies with perimysial pathologyClinical and laboratory featuresRobert C. Bucelli, Alan Pestronk et al.Neurology: Neuroimmunology & Neuroinflammation, January 18, 2018